US FDA Now Requires GCP Statement For Foreign Trial Data
Executive Summary
A regulation finalized last year kicks in today requiring companies to either include along with US FDA submissions a statement affirming Good Clinical Practice compliance for any data collected outside the US, or get a waiver.